Alimera Sciences Inc (ALIM) SEC Filing 8-K Material Event for the period ending Friday, May 1, 2020

Alimera Sciences Inc

CIK: 1267602 Ticker: ALIM

View differences made from one to another to evaluate Alimera Sciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alimera Sciences Inc.


Assess how Alimera Sciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alimera Sciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Alimera Sciences Inc provided additional information to their SEC Filing as exhibits

Ticker: ALIM
CIK: 1267602
Form Type: 8-K Corporate News
Accession Number: 0001267602-20-000079
Submitted to the SEC: Fri May 01 2020 4:39:56 PM EST
Accepted by the SEC: Fri May 01 2020
Period: Friday, May 1, 2020
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: